We use cookies to improve our services. Read more about how we use cookies and how you can refuse them.
2019
EMCDDA
EMCDDA Harm Reduction Initiative
2019
Clinical Gastroenterology and Hepatology
Coffee and Caffeine Are Associated With Decreased Risk ofAdvanced Hepatic Fibrosis Among Patients With Hepatitis C
2019
Hindawi Publishing Corporation
Linoleic Acid Induced Acute Hepatitis: A Case Report and Review of the Literature
2019
Endocrinology 2015
Fish Oil Rich Diet Promotes Hematopoiesis and AltersHematopoietic Niche
2019
HCV Advocate Magazine, 2015
A Brief Overview of Liver Toxic Herbs
2019
Gastroenterology 2015
Association Between Psychological Distress and Liver DiseaseMortality: A Meta-analysis of Individual Study Participants
2019
Gastroenterology 2015
On Stress and the Liver: A Chicken and Egg Conundrum
2019
Hepatitis Central
Tired with Hep C? Avoid These5 Foods!
2019
Hepatitis Central
Top 10 Sources of ProteinIntake for Hepatitis C
2019
Chinese medicine
Traditional Chinese Medicine and HCV
2019
Journal of Hepatology
Complementary and alternative therapies in the treatment of chronic hepatitis C: a systematic review.
2019
Hepatology
How Does Coffee Prevent Liver Fibrosis? Biological Plausibility for Recent Epidemiological Observations
2019
Alternative Medicine Review, Volume 4, Number 4
Hepatitis C - Epidemiology and Review of Complementary/Alternative Medicine Treatments
2019
Get The Facts
Hepatitis C Focus on Dietary Supplements
2019
CID 2013
Marijuana does not Accelerate Liver Disease in HIV–HCV Coinfection
2019
Gastroenterology 2014
Increased Intake of Vegetables, but not Fruit, Reduces Risk for HepatocellularCarcinoma: A Meta-analysis
2019
Hepatitis Central
The Top Three Alternative Treatments for Hepatitis C
2019
Addiction
Decline in incidence of HIV and hepatitis C virusinfection among injecting drug users in Amsterdam;evidence for harm reduction?
2019
The Lancet
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
2019
Journal of Viral Hepatitis, 2015
Estimates on HCV Disease Burden Worldwide - filling the gaps
2019
The bleach procedure
2019
The Lancet. August 16, 2018
Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis
2019
Health Promotion Practice, Lauren Knight et al.
Talking About Hepatitis C: FAQs From Young Adults Who Inject Drugs
2019
International Journal of Drug Policy 52 (2018) 16–19
Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia. Tamar Kikvidze et al.
2019
J Hepatol (2017)
Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients. Carriere MP et al.
2019
BMC Medicine (2019) 17:71
Improving engagement with healthcare in hepatitis C: a randomised controlled trial of a peer support intervention, R. Stagg et. al.
2019
The Lancet October 23, 2017
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. Larney, et. Al
2019
Infect Dis Clin N Am 32 (2018) 395–405
Understanding and Addressing Hepatitis C Virus Reinfection Among Men Who Have Sex with Men, Martin et al
2019
Treatment Action Group
Training Manual for Treatment Advocates; Hepatitis C Virus & coinfection with HIV, Annette Gaudino, Bryn Gay, and Tim Horn
2019
Correlation, INPUD, Swedish Drug User Union
Liver or Die: HCV Training for Peer Workers
2019
Correlation
Hepatitis B and C testing: Why? Who? How?
2019
Correlation
Hepatitis C Testing in the Community
2019
Correlation
Online Peer Support Manual
2019
E. Gupta et al. Journal of Clinical Virology 88 (2017) 46–51
Point -of -care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection
2019
Infect Dis Clin N Am 32 (2018) 371–393
Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs. Martinello et al
2019
Journal of Hepatology 2018
Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe. Fraser H et al.
2019
The Journal of Infectious Diseases 2018;217:466–73
Recovery of Infectious Hepatitis C Virus From Injection Paraphernalia: Implications for Prevention Programs Serving People Who Inject Drugs. Heimer et al.
2019
Journal of Hepatology 2017
M. Hellard et al. Achieving hepatitis C elimination in Europe – To treatment scale-up and beyond
2019
Jeffrey V. Lazarus et al. Journal of Hepatology 2017
Micro-elimination – A path to global elimination of hepatitis C
2019
J.Farrell, E.Schatz 2019 Correlation European Harm Reduction Network
Legal Barriers for Providing HCV Community Testing in Europe
2019
Correlation European Harm Reduction Network
HCV in Integrated Harm Reduction Services
2019
Correlation European Harm Reduction Network
Hepatitis C Community Summit 2018
2019
Correlation European Harm Reduction Network
HCV Community Testing
2019
Carmen Rossi et al, Journal of Hepotology Nov 2018
Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort
2019
International Journal of Drug Policy 62 (2018) 104–111
Direct acting antiviral-based treatment of hepatitis C virus infection among people who inject drugs in Georgia: A prospective cohort study
2019
The Lancet. Published Online January 28, 2019
Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model. Alastair Heffernan et al.
2019
Journal of Hepatology 2017
Achieving hepatitis C elimination in Europe – To treatment scale-up and beyond. M. Hellard et al.
2019
Lancet Gastroenterol Hepatol 2018
Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis
2019
2017 European Association for the Study of the Liver.
Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients, Maria P. Carrieri, et al.
2019
Infect Dis Clin N Am 32 (2018) 425–445
Hepatitis C Virus Diagnosis and the Holy Grail
2019
www.thelancet.com
EASL Commission on liver diseases in Europe: overcoming unmet needs, stigma, and inequities
2019
Hepatology, January 2019
Has Access to Hepatitis C Virus Therapy Changed for Patients With Mental Health or Substance Use Disorders in the Direct-Acting-Antiviral Period? Jain et, al
2019
WHO Regional Office for Europe
Action plan for the health sector response to viral hepatitis in the WHO European Region
2019
The Lancet: VOLUME 5, ISSUE 12, PE1208-E1220, DECEMBER 01, 2017
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review
2019
Journal of Hepatology 2018 Mar
Achieving hepatitis C elimination in Europe – To treatment scale-up and beyond
2019
WHO Regional Office for Europe
Action plan for the health sector response to viral hepatitis in the WHO European Region
2019
Am J Public Health.
Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014. Zibbell et al.
2019
J. Walker et al. bioRxiv preprint first posted online Feb. 24, 2018
Interim impact evaluation of the hepatitis C virus elimination program in Georgia
2019
World Health Organization; 2019
Progress report on HIV, viral hepatitis and sexually transmitted infections, 2019 Accountability for the global health sector strategies, 2016–2021
2019
EMCDDA 2019
Hepatitis C: New Models of Care for Drug Services
2019
WHO
WHO Hepatitis C Fact Sheet
2019
TAG 2019
Treatment Action Group: Pipeline Report HCV Diagnostics
2019
TAG 2019
Treatment Action Group: Pipeline Report HCV Treatments
2019
TAG 2019
Treatment Action Group: Hepatitis Fact Sheets
2019
Hep C Coalition 2019
Hep C Coalition: Fact Sheets for Compreensive HCV Services for People Who Use Drugs
2019
European Association for the Study of the Liver. EASL Recommendations on Treatment of Hepatitis C 2018. J Hepatol (2018)
EASL Recommendations on Treatment of Hepatitis C 2018
2019
European Centre for Disease Prevention and Control, 2017
ECDC Technical Report Hepatitis B and C testing activities, needs, and priorities in the EU/EEA
2019
ECDC 2019
Public Health Guidance on HIV, HBV and HCV Testing in the EU/EEA
2019
Liverpool University
University of Liverpool HCV Medication Interaction Website
2019
Correlation
Monitoring of HCV testing in low threshold drug services - Heike Zurhold
2019
Correlation
Drug Consumption Rooms: Evidence and Practice
2019
Correlation
Data Collection Protocal for Specialist Harm Reduction Agencies
2019
Correlation
Evaluation Guide
2019
WHO Regional Office for Europe
Action plan for the health sector response to viral hepatitis in the WHO European Region
2019
Am J Public Health.
Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014. Zibbell et al.
2019
Journal of Hepatology 2017
Achieving hepatitis C elimination in Europe – To treatment scale-up and beyond. M. Hellard et al.
2019
2017 European Association for the Study of the Liver.
Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients, Maria P. Carrieri, et al.
2020
ECDC
Monitoring the responses tohepatitis B and C epidemicsin the EU/EEA Member States2019
2020
BMC Infectious Diseases
Beyond clinical outcomes: the social andhealthcare system implications of hepatitisC treatment
2019
WHO Regional Office for Europe
Action plan for the health sector response to viral hepatitis in the WHO European Region
2020
EASL
EASL Policy Statement:Drug use and the global hepatitis C elimination goal
2016
Improving testing rates for blood-borne viruses in prisons and other secure settings